T cell-mediated immunity affects the CP and attenuates the secretion of IL-4 (interleukin 4) [98], which has been shown to be associated with brain aging and may serve as a therapeutic target for reversing or halting age-related diseases such as dementia [99]. The gene discussed is IL4; the disease is dementia.